Seven Eight Capital’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-36,046
Closed -$1.49M 693
2023
Q1
$1.49M Buy
+36,046
New +$1.54M 0.31% 92
2020
Q1
Sell
-4,826
Closed -$373K 770
2019
Q4
$373K Sell
4,826
-2,500
-34% -$177K 0.02% 567
2019
Q3
$464K Buy
+7,326
New +$458K 0.02% 522
2018
Q1
Sell
-50,483
Closed -$2.95M 573
2017
Q4
$2.95M Buy
50,483
+25,400
+101% +$1.44M 0.3% 118
2017
Q3
$1.39M Buy
+25,083
New +$1.66M 0.17% 196
2017
Q2
Sell
-8,900
Closed -$665K 702
2017
Q1
$665K Sell
8,900
-10,200
-53% -$740K 0.13% 232
2016
Q4
$1.29M Buy
+19,100
New +$1.23M 0.26% 143
2016
Q3
Sell
-7,300
Closed -$436K 589
2016
Q2
$436K Buy
7,300
+4,900
+204% +$265K 0.15% 211
2016
Q1
$117K Buy
+2,400
New +$109K 0.05% 366
2015
Q4
Sell
-300
Closed -$14K 719
2015
Q3
$14K Sell
300
-6,600
-96% -$341K 0.01% 432
2015
Q2
$327K Buy
+6,900
New +$323K 0.39% 79

Other funds holding NUVA

Seven Eight Capital's NUVA Position: Q2 2023 in Review

Seven Eight Capital sold out of NuVasive, Inc. (NUVA) in Q2 2023, closing a stake of 36,046 shares — an estimated $1.49M sold.

Seven Eight Capital first reported a position in NUVA in Q2 2015 and held it in 11 quarters. The position peaked at $2.95M in Q4 2017. 228 funds tracked by Wall St. Rank hold NUVA as of Q2 2023.

  • Seven Eight Capital reported no remaining NuVasive, Inc. position as of Q2 2023 after selling out during the quarter.
  • Seven Eight Capital sold 36,046 NuVasive, Inc. shares in Q2 2023, an estimated $1.49M.
  • Seven Eight Capital first reported a position in NuVasive, Inc. in Q2 2015 and held it in 11 quarters.
  • Seven Eight Capital's NuVasive, Inc. position peaked at $2.95M in Q4 2017.
  • 228 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2023.

Based on Seven Eight Capital's 13F filing for Q2 2023, filed 14 Aug 2023.